Baxter International Inc. (LON:0QK8)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 9.26B |
| Revenue (ttm) | 7.95B |
| Net Income (ttm) | -113.13M |
| Shares Out | n/a |
| EPS (ttm) | -0.23 |
| PE Ratio | n/a |
| Forward PE | 9.79 |
| Dividend | 0.62 (2.55%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 1,548 |
| Average Volume | 6,330 |
| Open | 24.79 |
| Previous Close | 24.35 |
| Day's Range | 24.09 - 24.79 |
| 52-Week Range | 21.35 - 40.31 |
| Beta | n/a |
| RSI | 41.37 |
| Earnings Date | Jul 31, 2025 |
About Baxter International
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]
News
Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio?
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio ? 1. Novo Nordisk (NYSE: NVO) has slumped over 31% this week after the company lowered its 2025 sales...
Baxter cut to Neutral at Goldman Sachs after Q2 miss
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo...
President Trump demands drugmakers slash prices within 60 days
CNBC's Joe Kernen reports on the latest news.
Baxter (BAX) Q2 Revenue Rises 4%
Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook
Baxter International Inc. (NYSE: BAX) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low. ...
Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook
Q2 adjusted EPS was $0.59, matching guidance but slightly below the $0.61 Street estimate. FY25 EPS forecast lowered to $2.42–$2.52 vs. prior range of $2.47–$2.55.
This Is What Whales Are Betting On Baxter Intl
Financial giants have made a conspicuous bullish move on Baxter Intl. Our analysis of options history for Baxter Intl (NYSE: BAX) revealed 17 unusual trades. Delving into the details, we found 52% of...
Baxter International Inc. 2025 Q2 - Results - Earnings Call Presentation
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsClare Trachtman - Vice President of...
Baxter slumps as Medical Products & Therapies drive Q2 revenue miss
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing fa...
Baxter Reports Second-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delivere...
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
Baxter the Brave Mouse Unites Baxterville Against the Cat Pack
Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the C...
Baxter: Margin-Focused Model Faces Growth Constraints
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, ...
Baxter declares $0.17 dividend
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2212289210-ecb882996249447fb55b294b486bff46.jpg)
Medical Equipment Maker Baxter International Names New CEO
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO. Shares of both companies fell.
Baxter International Names ATS Hider as Next Chief Executive Officer
Baxter appoints Andrew Hider as CEO
Baxter International Names Andrew Hider as CEO
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Baxter Appoints Andrew Hider Chief Executive Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a m...